ModivCare Inc. (MODV)
USD 1.46
(5.8%)
USD 1.46
(5.8%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 983.75 Million USD | -2.74% |
| 2022 | 1.01 Billion USD | 0.17% |
| 2021 | 1 Billion USD | 98.22% |
| 2020 | 509.41 Million USD | 3401.87% |
| 2019 | 14.54 Million USD | 4020.96% |
| 2018 | 353 Thousand USD | -39.55% |
| 2017 | 584 Thousand USD | -69.1% |
| 2016 | 1.89 Million USD | -99.31% |
| 2015 | 272.47 Million USD | -43.77% |
| 2014 | 484.52 Million USD | 543.89% |
| 2013 | 75.25 Million USD | -35.13% |
| 2012 | 116 Million USD | -17.43% |
| 2011 | 140.49 Million USD | -14.43% |
| 2010 | 164.19 Million USD | -12.07% |
| 2009 | 186.73 Million USD | -16.45% |
| 2008 | 223.49 Million USD | -5.49% |
| 2007 | 236.46 Million USD | 38121.48% |
| 2006 | 618.68 Thousand USD | -95.66% |
| 2005 | 14.24 Million USD | 1843.14% |
| 2004 | 732.88 Thousand USD | -67.27% |
| 2003 | 2.23 Million USD | -79.32% |
| 2002 | 10.83 Million USD | -98.94% |
| 2001 | 1.02 Billion USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 984.89 Million USD | 0.12% |
| 2024 Q2 | 986.05 Million USD | 0.12% |
| 2023 Q3 | 1.01 Billion USD | 0.21% |
| 2023 Q1 | 1.01 Billion USD | 0.18% |
| 2023 Q4 | 983.75 Million USD | -3.18% |
| 2023 FY | 983.75 Million USD | -2.74% |
| 2023 Q2 | 1.01 Billion USD | 0.06% |
| 2022 FY | 1.01 Billion USD | 0.17% |
| 2022 Q1 | 1.01 Billion USD | 0.06% |
| 2022 Q2 | 1 Billion USD | -0.06% |
| 2022 Q3 | 1 Billion USD | -0.09% |
| 2022 Q4 | 1.01 Billion USD | 0.25% |
| 2021 Q1 | 508.91 Million USD | -0.1% |
| 2021 Q2 | 519.96 Million USD | 2.17% |
| 2021 Q3 | 1.01 Billion USD | 94.26% |
| 2021 FY | 1 Billion USD | 98.22% |
| 2021 Q4 | 1 Billion USD | -0.03% |
| 2020 Q1 | 12.98 Million USD | -10.72% |
| 2020 Q3 | 13.01 Million USD | -6.27% |
| 2020 Q2 | 13.88 Million USD | 6.92% |
| 2020 FY | 509.41 Million USD | 3401.87% |
| 2020 Q4 | 509.41 Million USD | 3814.08% |
| 2019 Q4 | 14.54 Million USD | -2.42% |
| 2019 FY | 14.54 Million USD | 4020.96% |
| 2019 Q1 | 14.87 Million USD | 4115.01% |
| 2019 Q2 | 14 Million USD | -5.85% |
| 2019 Q3 | 14.9 Million USD | 6.42% |
| 2018 Q2 | 507 Thousand USD | -21.27% |
| 2018 Q3 | 430 Thousand USD | -15.19% |
| 2018 Q4 | 353 Thousand USD | -17.91% |
| 2018 FY | 353 Thousand USD | -39.55% |
| 2018 Q1 | 644 Thousand USD | 10.27% |
| 2017 Q4 | 584 Thousand USD | 3.18% |
| 2017 Q2 | 1.13 Million USD | -5.67% |
| 2017 FY | 584 Thousand USD | -69.1% |
| 2017 Q1 | 1.19 Million USD | -36.56% |
| 2017 Q3 | 566 Thousand USD | -49.96% |
| 2016 Q3 | 450 Thousand USD | -99.84% |
| 2016 Q4 | 1.89 Million USD | 320.0% |
| 2016 FY | 1.89 Million USD | -99.31% |
| 2016 Q1 | 274.54 Million USD | 0.76% |
| 2016 Q2 | 272.82 Million USD | -0.62% |
| 2015 Q1 | 476.89 Million USD | -1.57% |
| 2015 FY | 272.47 Million USD | -43.77% |
| 2015 Q4 | 272.47 Million USD | -39.59% |
| 2015 Q2 | 458.66 Million USD | -3.82% |
| 2015 Q3 | 451.03 Million USD | -1.66% |
| 2014 Q1 | 74.5 Million USD | -1.0% |
| 2014 Q2 | 189.35 Million USD | 154.16% |
| 2014 FY | 484.52 Million USD | 543.89% |
| 2014 Q4 | 484.52 Million USD | 156.91% |
| 2014 Q3 | 188.6 Million USD | -0.4% |
| 2013 Q1 | 112.25 Million USD | -3.23% |
| 2013 Q4 | 75.25 Million USD | -0.99% |
| 2013 Q3 | 76 Million USD | 24.59% |
| 2013 FY | 75.25 Million USD | -35.13% |
| 2013 Q2 | 61 Million USD | -45.66% |
| 2012 Q2 | 134.24 Million USD | -2.72% |
| 2012 Q4 | 116 Million USD | -9.38% |
| 2012 FY | 116 Million USD | -17.43% |
| 2012 Q1 | 137.99 Million USD | -1.78% |
| 2012 Q3 | 128 Million USD | -4.65% |
| 2011 Q3 | 142.99 Million USD | -9.22% |
| 2011 FY | 140.49 Million USD | -14.43% |
| 2011 Q4 | 140.49 Million USD | -1.75% |
| 2011 Q2 | 157.52 Million USD | 2.71% |
| 2011 Q1 | 153.37 Million USD | -6.59% |
| 2010 Q1 | 177.77 Million USD | -4.8% |
| 2010 FY | 164.19 Million USD | -12.07% |
| 2010 Q4 | 164.19 Million USD | -2.68% |
| 2010 Q3 | 168.71 Million USD | -2.61% |
| 2010 Q2 | 173.24 Million USD | -2.55% |
| 2009 FY | 186.73 Million USD | -16.45% |
| 2009 Q1 | 219.16 Million USD | -1.94% |
| 2009 Q2 | 212.72 Million USD | -2.94% |
| 2009 Q3 | 208.4 Million USD | -2.03% |
| 2009 Q4 | 186.73 Million USD | -10.4% |
| 2008 FY | 223.49 Million USD | -5.49% |
| 2008 Q4 | 223.49 Million USD | -1.43% |
| 2008 Q3 | 226.73 Million USD | -1.41% |
| 2008 Q2 | 229.98 Million USD | -1.39% |
| 2008 Q1 | 233.22 Million USD | -1.37% |
| 2007 FY | 236.46 Million USD | 38121.48% |
| 2007 Q4 | 236.46 Million USD | 1470.58% |
| 2007 Q2 | 6.49 Million USD | 949.6% |
| 2007 Q1 | 618.68 Thousand USD | 0.0% |
| 2007 Q3 | 15.05 Million USD | 131.86% |
| 2006 Q4 | 618.68 Thousand USD | 0.0% |
| 2006 Q3 | 618.68 Thousand USD | -1.33% |
| 2006 Q2 | 627.02 Thousand USD | -95.23% |
| 2006 FY | 618.68 Thousand USD | -95.66% |
| 2006 Q1 | 13.14 Million USD | -7.67% |
| 2005 Q3 | 15.3 Million USD | 66.73% |
| 2005 Q2 | 9.18 Million USD | 1391.65% |
| 2005 Q1 | 615.45 Thousand USD | -16.02% |
| 2005 Q4 | 14.24 Million USD | -6.96% |
| 2005 FY | 14.24 Million USD | 1843.14% |
| 2004 Q3 | 858.68 Thousand USD | -13.12% |
| 2004 Q2 | 988.4 Thousand USD | -11.31% |
| 2004 Q1 | 1.11 Million USD | -50.23% |
| 2004 Q4 | 732.88 Thousand USD | -14.65% |
| 2004 FY | 732.88 Thousand USD | -67.27% |
| 2003 Q4 | 2.23 Million USD | -30.56% |
| 2003 FY | 2.23 Million USD | -79.32% |
| 2003 Q3 | 3.22 Million USD | -77.23% |
| 2003 Q2 | 14.16 Million USD | 0.0% |
| 2002 FY | 10.83 Million USD | -98.94% |
| 2001 Q4 | 1.02 Billion USD | 0.0% |
| 2001 FY | 1.02 Billion USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 26.725% |
| Addus HomeCare Corporation | 124.13 Million USD | -692.509% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -1315.417% |
| Amedisys, Inc. | 346.76 Million USD | -183.698% |
| Astrana Health, Inc. | 296.26 Million USD | -232.058% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 22.924% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | -822.589% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -10498.574% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -36841.682% |
| COMPASS Pathways plc | 28.75 Million USD | -3320.931% |
| DocGo Inc. | 15.16 Million USD | -6388.341% |
| The Ensign Group, Inc. | 1.78 Billion USD | 44.882% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -8656.182% |
| InnovAge Holding Corp. | 100.49 Million USD | -878.902% |
| The Joint Corp. | 2 Million USD | -49087.85% |
| LifeStance Health Group, Inc. | 280.28 Million USD | -250.985% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -257806.769% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -826732.466% |
| Option Care Health, Inc. | 1.05 Billion USD | 6.898% |
| P3 Health Partners Inc. | 108.31 Million USD | -808.204% |
| P3 Health Partners Inc. | 108.31 Million USD | -808.204% |
| The Pennant Group, Inc. | 312.51 Million USD | -214.792% |
| Surgery Partners, Inc. | 2.03 Billion USD | 51.625% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -1033.021% |
| The Oncology Institute, Inc. | 86.82 Million USD | -1033.021% |